|
ACTL6A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.936200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.521200E-01 |
| Normal-vs-Stage2 |
1.841570E-02 |
| Normal-vs-Stage3 |
1.962360E-01 |
| Normal-vs-Stage4 |
1.765360E-01 |
| Stage1-vs-Stage2 |
1.032440E-02 |
| Stage1-vs-Stage3 |
1.816570E-01 |
| Stage1-vs-Stage4 |
1.600050E-01 |
| Stage2-vs-Stage3 |
1.504220E-01 |
| Stage2-vs-Stage4 |
1.839000E-01 |
| Stage3-vs-Stage4 |
9.373000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.834800E-01 |
| Normal-vs-AfricanAmerican |
9.453200E-01 |
| Normal-vs-Asian |
7.088400E-01 |
| Caucasian-vs-AfricanAmerican |
6.903400E-01 |
| Caucasian-vs-Asian |
2.925000E-01 |
| AfricanAmerican-vs-Asian |
7.458400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.604000E-02 |
| Normal-vs-Female |
5.115000E-01 |
| Male-vs-Female |
1.553390E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.675200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.107240E-01 |
| Normal-vs-Age(61-80Yrs) |
2.099900E-02 |
| Normal-vs-Age(81-100Yrs) |
4.823800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.456000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.715100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.858000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.167800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.588200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.187630E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.821600E-01 |
| Classical-VS-Follicular |
3.74359987453943E-10 |
| Classical-VS-Other |
6.889400E-01 |
| Classical-VS-Normal |
6.062800E-01 |
| Tall-VS-Follicular |
1.989520E-04 |
| Tall-VS-Other |
5.641800E-01 |
| Tall-VS-Normal |
3.849000E-01 |
| Follicular-VS-Other |
1.427810E-01 |
| Follicular-VS-Normal |
4.25350000000657E-05 |
| Other-VS-Normal |
8.398400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.384470E-02 |
| Normal-vs-N1 |
4.328800E-01 |
| N0-vs-N1 |
2.692400E-01 |
|
|
